Researchers examine the main mechanisms of drug resistance currently being studied, including drug resistance-related proteins and enzymes, gene alterations, micro RNAs, and signal pathways.
[Cancer Management and Research] Accumulating evidences showed some positive relations between MI and new onset cancer.
[Breast Cancer: Targets and Therapy] A review of conventional and novel therapies for breast cancer, as well as an investigation into the role of breast cancer stem cells in treatment resistance and what’s in the pipeline to combat that resistance.
This report presents case studies of two patients with breast cancer BM (BCBM) who reacted to two different forms of endocrine therapy.
[OncoTargets and Therapy] This review focuses on the value of using nal-IRI, toxicities, recent clinical experiences, and tools to improve outcomes for patients receiving gemcitabine-based therapy.
[Blood and Lymphatic Cancer: Targets and Therapy] This review examines the significance of MRD in different settings and the main markers and methods used for MRD detection.
Researchers report on trends in incidence, treatment, and survival across various demographic populations over the last 40 years.
[Cancer Management and Research] Researchers report on the efficacy of palliative CSI in alleviating neurologic symptoms or delaying neurologic deterioration in patients with leptomeningeal carcinomatosis.
[OncoTargets and Therapy] A review of the role of radiation therapy and potential prognostic factors for selecting patients for more radical treatment.
[Breast Cancer: Targets and Therapy] A review of the potential of immunotherapy along and in combination with standard therapies for breast cancer, in particularly HER2-positive expressing subtypes.